Cybersecurity
Background Image
tabs dropdown arrow
Message from the CISO

Cybersecurity is one of the most critical issues impacting the healthcare industry. At BD, we maintain an unwavering commitment to security by design, in use and through partnership. We strive to ensure our products, systems and customer environments maintain high security standards so our customers can focus on what matters most: caring for patients.

While we maintain robust security protocols, we also recognize that new security threats emerge daily, from attempts to compromise healthcare data to coordinated efforts to disrupt clinical workflows or manufacturing. We recognize that our customers cannot protect what they don’t know. That’s why we believe transparency and collaboration are essential. As we build a strong community of practice, working closely with our customers, industry regulators, and security researchers, we’re improving cybersecurity and resilience across the industry.

— Rob Suárez, Vice President and Chief Information Security Officer

Our Priorities
Our Framework

BD Cybersecurity Framework

BD utilizes a framework to incorporate cybersecurity into our processes for product design, manufacturing, customer support and enterprise systems. Our framework has been aligned to various industry work products including the HSCC Joint Security Plan, NIST Cybersecurity Framework, ISO 27001, UL 2900 and ISA 62443.

×
Certifications and Attestations

Access BD cybersecurity resources

BD recognizes the value to our customers of independent cybersecurity attestation. Each year a range of third-party audits are performed on BD products and internal cybersecurity controls. To demonstrate our commitment to product security and the protection of customer data, BD makes these industry recognized certifications and attestation reports available to customers.

BD maintains a SOC2+ program for multiple BD products that collect and process patient health information in accordance with the HIPAA security rule. These annual audits address the Trust Principles for Security and, for our cloud-based products, Availability. These reports are prepared by an independent third party and provide assurance regarding the operational effectiveness of BD internal controls and the security of BD products.

UL CAP, which stands for Underwriters Laboratories Cybersecurity Assurance Program, is an independently audited certification that demonstrates the cybersecurity of medical device products through a rigorous program of analysis. UL CAP cybersecurity testing is extensive and challenges BD products against known cybersecurity vulnerabilities, malware, malformed input (fuzz testing), structured penetration, static source code analysis, static binary and bytecode analysis, and verification of security controls (access control, user authentication and authorization, remote communication, cryptography and software updates).

BD maintains Product Security White Papers for its software-enabled products. The purpose of these documents is to provide details on how BD security and privacy practices have been applied and what our customers should know about maintaining security throughout the entire product lifecycle. Each white paper includes a Manufacturer Disclosure Statement for Medical Device Security (MDS2 attestation).

Download and Request Information

SOC2+ reports and Product Security White Papers are restricted to existing BD customers and can be requested below. UL CAP certificates display the scope (product and version), validity period, and certifying UL Manager and can be downloaded below. Prospective customers that wish to obtain copies of SOC2+ reports or Product Security White Papers can request these from their sales representative following approval of a Confidential Disclosure Agreement (CDA). Select the documents you would like to access and use the icons at the bottom of the page to trigger the download or request.

BD™ Universal Viral Transport System
Product Request SOC2 report Download UL CAP certificate Request BD product security white paper
BD Knowledge Portal for BD Pyxis™ Supply Technologies
BD Pyxis™ SupplyStation system
BD Pyxis™ medication technologies
Product Request SOC2 report Download UL CAP certificate Request BD product security white paper
BD Knowledge Portal for BD Pyxis™ Medication Technologies
BD Pyxis™ Anesthesia Station
BD Pyxis™ CIISafe
BD Pyxis™ Anesthesia Station ES
BD Alaris™ PCU
Product Request SOC2 report Download UL CAP certificate Request BD product security white paper
BD Knowledge Portal for BD Pyxis™ Medication Technologies
BD Pyxis™ Anesthesia Station
BD Pyxis™ CIISafe
BD Pyxis™ Anesthesia Station ES
BD HealthSight™ analytics
Product Request SOC2 report Download UL CAP certificate Request BD product security white paper
BD Knowledge Portal for BD Pyxis™ Medication Technologies
BD Pyxis™ Anesthesia Station
BD Pyxis™ CIISafe
BD Pyxis™ Anesthesia Station ES
Request Documents
Page CybersecurityPages
Filters
Clear

Filters

Browse All Bulletins and Patches
Sort by :
Relevance
Relevance Latest Oldest Name (A-Z) Name (Z-A)

Your search did not match any documents.
help-icon
Search Tips:
  • Check the Knowledge Center for literature, case studies, events, or other documents
  • Explore our Products and Solutions
  • Search for related topics of interest using the search bar above, then try modifying your search using the filters at left
  • Check our Support pages or Contact Us
  • Try to search for similar words and pages
  • Check your spelling
Form
Process Overview

Coordinated Vulnerability Disclosure

BD has established a routine practice of seeking, communicating, and addressing cybersecurity issues in a timely fashion. Vulnerability disclosure is an essential component to our approach to transparency by enabling customers to manage risk properly through awareness and guidance.

Process

Report Report
Report
Analyze Analyze
Analyze
Coordinate Coordinate
Coordinate
Disclose Disclose
Disclose
Customer Customer
Customer
BD welcomes vulnerability reports from security researchers, customers, third-party component vendors and other external groups that wish to report a vulnerability in a BD software-enabled device. 
But from the point of order to patient administration, there are 30 workflow steps that carry a 45% risk of error. Considering many healthcare systems process an average of 20,000 doses per day, the impact can be massive.
But from the point of order to patient administration, there are 30 workflow steps that carry a 45% risk of error. Considering many healthcare systems process an average of 20,000 doses per day, the impact can be massive.
But from the point of order to patient administration, there are 30 workflow steps that carry a 45% risk of error. Considering many healthcare systems process an average of 20,000 doses per day, the impact can be massive.
But from the point of order to patient administration, there are 30 workflow steps that carry a 45% risk of error. Considering many healthcare systems process an average of 20,000 doses per day, the impact can be massive.
Cybersecurity Annual Report

Find out how BD is advancing the world of health™  by driving collaboration across the industry, supporting our customers, and addressing the most pervasive cybersecurity challenges impacting the infrastructure of healthcare around the world.

News and Media
  • July 27, 2021

    BD CISO talks cybersecurity best practices, previews HIMSS21

    BD Chief Information Security Officer Rob Suárez previews the company's upcoming cybersecurity panel discussion at HIMSS and discusses transparency and collaboration.

    Learn More

    forward-arrow
  • June 22, 2021

    Using a Medical Device Software Bill of Materials

    BD Chief Information Security Officer Rob Suárez speaks with Marianne Kolbasuk McGee about medical device security challenges.

    Learn More

    forward-arrow
  • June 9, 2021

    Medtech Needs to Be 'Proactive' When It Comes to Cybersecurity, Says Expert from BD

    For BD, being transparent about potential vulnerabilities is essential because customers can’t protect what they don’t know.

    Learn More

    forward-arrow
  • June 2, 2021

    BD Advances Leadership in Cybersecurity Preparedness, Transparency

    BD becomes the first medical technology company authorized as a Common Vulnerability and Exposures (CVE®) Numbering Authority by the CVE Program, further demonstrating company's leadership in health care cybersecurity.

    Learn More

    forward-arrow
  • July 27, 2021

    BD CISO talks cybersecurity best practices, previews HIMSS21 2

    BD Chief Information Security Officer Rob Suárez previews the company's upcoming cybersecurity panel discussion at HIMSS and discusses transparency and collaboration.

    Learn More

    forward-arrow
  • June 22, 2021

    Using a Medical Device Software Bill of Materials

    BD Chief Information Security Officer Rob Suárez speaks with Marianne Kolbasuk McGee about medical device security challenges.

    Learn More

    forward-arrow

Report a potential product-related security issue, such as an incident, breach or vulnerability

Chat with us
Our live chat is available between the hours of 8.30am - 5.00pm EST, Monday - Friday
×